Skip to content
2000
Volume 4, Issue 3
  • ISSN: 1573-4048
  • E-ISSN: 1875-6581

Abstract

Endometriosis is an enigmatic, debilitating disease which affects as many as 15% of all women of reproductive age and is characterized by pelvic pain and infertility. Current treatment regimes used to manage the disease do so by inducing a hypoestrogenic state. While the absence of circulating estrogen levels lead to a regression of the disease, this hypoestrogenism also induces many unpleasant side-effects. As such, these and other shortcomings of current drug therapies emphasize their limitations and the necessity for the development of novel endometriosis treatments. In this review, current therapies for medical management of endometriosis are discussed as are their shortcomings. Potential target areas which may be attractive alternatives to current therapies are also reviewed. Emphasis is placed upon the emerging research using TNF inhibitors, their potential benefits over current treatment regimes and the development of future potential therapeutic targets.

Loading

Article metrics loading...

/content/journals/cwhr/10.2174/157340408785821746
2008-08-01
2025-05-25
Loading full text...

Full text loading...

/content/journals/cwhr/10.2174/157340408785821746
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test